$ANVS
Annovis Bio, Inc.
XNYS•Health Care•Pharmaceutical Preparations
$1.11
▼-8.26%-$0.100
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ANVS down today? It is at $1.11 (-8.26%), and our scanner flagged it 61 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ANVS spikes, and full due diligence on ANVS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ANVS 61 times in the last 30 days. Create a free account to track $ANVS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ANVS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hoffman Michael B Director | Bought (open market) | +76K 0.2% of company | added 2.3% | 3.36M | $134K at $1.75 | May 20, 26 |
Hoffman Michael B Director | Bought (open market) | +714K 1.7% of company | added 28% | 3.29M | $1.5M at $2.10 | Apr 2, 26 |
Hoffman Michael B Director | Bought (open market) | +45K 0.1% of company | added 1.8% | 2.57M | $191K at $4.24 | Dec 8, 25 |
Hoffman Michael B Director | Bought (open market) | +39K 0.09% of company | added 1.6% | 2.52M | $151K at $3.85 | Nov 24, 25 |
Hoffman Michael B Director | Bought (open market) | +20K 0.05% of company | added 0.8% | 2.49M | $70K at $3.49 | Nov 21, 25 |
Hoffman Michael B Director | Bought (open market) | +15K 0.04% of company | added 0.6% | 2.47M | $32K at $2.11 | Nov 14, 25 |
Hoffman Michael B Director | Bought (open market) | +976K 2.3% of company | added 66% | 2.46M | $2.0M at $2.05 | Oct 28, 25 |
Maccecchini Maria-Luisa Officer | Bought (open market) | +98K 0.2% of company | added 8.8% | 1.21M | $200K at $2.05 | Oct 28, 25 |
Bruck Claudine Director | Other | 7K 0.02% of company | added 100% | 14K | $1000 at $0.140 | Sep 10, 25 |
Hoffman Michael B Director | Acquired (grant/award) | +15K 0.04% of company | added 1.0% | 1.48M | $34K at $2.28 | Aug 29, 25 |
Hoffman Michael B Director | Acquired (grant/award) | +19K 0.04% of company | added 1.3% | 1.46M | $48K at $2.57 | Aug 19, 25 |
Walsh Andrew Officer | Acquired (grant/award) | +500 | n/a | 500 | $1K at $2.90 | Jun 16, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ANVS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ANVS last traded at $1.11, down 8.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Annovis Bio, Inc. (ANVS) is next expected to report earnings on Wednesday, November 11, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ANVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ANVS 61 times in the last 30 days.
ANVS (Annovis Bio, Inc.) trades on XNYS, with a market cap of about $52M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ANVS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ANVS discussion
Sign in to ask a question or join the discussion.